ZA200202863B - Novel cell cycle checkpoint genes and proteins encoded thereby. - Google Patents
Novel cell cycle checkpoint genes and proteins encoded thereby.Info
- Publication number
- ZA200202863B ZA200202863B ZA200202863A ZA200202863A ZA200202863B ZA 200202863 B ZA200202863 B ZA 200202863B ZA 200202863 A ZA200202863 A ZA 200202863A ZA 200202863 A ZA200202863 A ZA 200202863A ZA 200202863 B ZA200202863 B ZA 200202863B
- Authority
- ZA
- South Africa
- Prior art keywords
- cell cycle
- proteins encoded
- cycle checkpoint
- checkpoint genes
- novel cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15383699P | 1999-09-14 | 1999-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200202863B true ZA200202863B (en) | 2003-09-23 |
Family
ID=22548950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200202863A ZA200202863B (en) | 1999-09-14 | 2002-04-11 | Novel cell cycle checkpoint genes and proteins encoded thereby. |
Country Status (15)
Country | Link |
---|---|
US (3) | US6440732B1 (de) |
EP (1) | EP1214453B1 (de) |
JP (1) | JP4871468B2 (de) |
KR (2) | KR100851511B1 (de) |
AT (1) | ATE404693T1 (de) |
AU (1) | AU784443B2 (de) |
CA (1) | CA2385266C (de) |
DE (1) | DE60039895D1 (de) |
DK (1) | DK1214453T3 (de) |
ES (1) | ES2311472T3 (de) |
IL (2) | IL148595A0 (de) |
NO (1) | NO20021255L (de) |
NZ (1) | NZ518236A (de) |
WO (1) | WO2001020038A1 (de) |
ZA (1) | ZA200202863B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2507863A1 (en) * | 2002-12-04 | 2004-06-17 | Algos Therapeutics, Inc. | Methods and materials for modulating trpm2 |
US7396669B2 (en) * | 2004-06-30 | 2008-07-08 | The Scripps Research Institute | Mammalian endonucleases and methods of use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
US5552390A (en) * | 1993-12-09 | 1996-09-03 | The Board Of Regents Of The University Of Nebraska | Phosphorothioate inhibitors of metastatic breast cancer |
EP0973935A2 (de) * | 1997-03-20 | 2000-01-26 | Variagenics, Inc. | Allele spezifische zielgene |
US5977341A (en) * | 1998-11-20 | 1999-11-02 | Isis Pharmaceuticals Inc. | Antisense modulation of inhibitor-kappa B kinase-beta expression |
US7396669B2 (en) * | 2004-06-30 | 2008-07-08 | The Scripps Research Institute | Mammalian endonucleases and methods of use |
-
2000
- 2000-09-14 KR KR1020027003418A patent/KR100851511B1/ko not_active IP Right Cessation
- 2000-09-14 WO PCT/US2000/025278 patent/WO2001020038A1/en active IP Right Grant
- 2000-09-14 KR KR1020077005027A patent/KR100817010B1/ko not_active IP Right Cessation
- 2000-09-14 AT AT00965026T patent/ATE404693T1/de active
- 2000-09-14 IL IL14859500A patent/IL148595A0/xx active IP Right Grant
- 2000-09-14 DE DE60039895T patent/DE60039895D1/de not_active Expired - Lifetime
- 2000-09-14 DK DK00965026T patent/DK1214453T3/da active
- 2000-09-14 NZ NZ518236A patent/NZ518236A/en not_active IP Right Cessation
- 2000-09-14 CA CA2385266A patent/CA2385266C/en not_active Expired - Fee Related
- 2000-09-14 ES ES00965026T patent/ES2311472T3/es not_active Expired - Lifetime
- 2000-09-14 AU AU75817/00A patent/AU784443B2/en not_active Ceased
- 2000-09-14 US US09/661,711 patent/US6440732B1/en not_active Expired - Lifetime
- 2000-09-14 JP JP2001523807A patent/JP4871468B2/ja not_active Expired - Fee Related
- 2000-09-14 EP EP00965026A patent/EP1214453B1/de not_active Expired - Lifetime
-
2002
- 2002-03-10 IL IL148595A patent/IL148595A/en not_active IP Right Cessation
- 2002-03-13 NO NO20021255A patent/NO20021255L/no not_active Application Discontinuation
- 2002-04-11 ZA ZA200202863A patent/ZA200202863B/xx unknown
- 2002-08-27 US US10/229,355 patent/US7214790B2/en not_active Expired - Fee Related
-
2007
- 2007-05-08 US US11/800,929 patent/US7479541B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2311472T3 (es) | 2009-02-16 |
US20070213256A1 (en) | 2007-09-13 |
IL148595A0 (en) | 2002-09-12 |
DE60039895D1 (de) | 2008-09-25 |
EP1214453A4 (de) | 2003-02-19 |
KR20020064781A (ko) | 2002-08-09 |
NZ518236A (en) | 2004-02-27 |
US7214790B2 (en) | 2007-05-08 |
KR20070043872A (ko) | 2007-04-25 |
JP2003509069A (ja) | 2003-03-11 |
CA2385266C (en) | 2011-05-24 |
WO2001020038A1 (en) | 2001-03-22 |
CA2385266A1 (en) | 2001-03-22 |
KR100817010B1 (ko) | 2008-03-27 |
US7479541B2 (en) | 2009-01-20 |
JP4871468B2 (ja) | 2012-02-08 |
AU784443B2 (en) | 2006-04-06 |
DK1214453T3 (da) | 2008-10-13 |
EP1214453B1 (de) | 2008-08-13 |
IL148595A (en) | 2008-11-26 |
NO20021255D0 (no) | 2002-03-13 |
NO20021255L (no) | 2002-05-03 |
KR100851511B1 (ko) | 2008-08-11 |
AU7581700A (en) | 2001-04-17 |
ATE404693T1 (de) | 2008-08-15 |
US20070072794A1 (en) | 2007-03-29 |
EP1214453A1 (de) | 2002-06-19 |
US6440732B1 (en) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1824977T3 (pl) | Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki | |
HK1071375A1 (en) | Egviii endoglucanase and nucleic acids encoding the same egviii | |
WO2000012726A3 (en) | Rationally designed heparinases derived from heparinase i and ii | |
DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
WO2004101760A3 (en) | Novel lipolytic enzyme elip | |
EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
HK1158529A1 (en) | Promoters exhibiting endothelial cell specificity and methods of using same | |
NZ503020A (en) | Bacillus gene for secreted beta-glucuronidase | |
IL148595A0 (en) | Novel cell cycle checkpoint genes and proteins encoded thereby | |
WO2000021986A3 (en) | Matrix-remodeling genes | |
AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
ATE288491T1 (de) | Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren | |
WO2004029233A3 (en) | Mutant recombinases | |
WO2000008145A3 (en) | Novel genes in control of hematopoiesis | |
WO2000040607A3 (en) | Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor | |
ATE547427T1 (de) | Verfahren zur rekombinanten herstellung von ribonukleoproteinen | |
HK1039792A1 (en) | Negative-sense rna virus vetor for nerve cell | |
AU5233599A (en) | Ddkh-3 nucleic acids, polypeptides, vectors, host cells, methods and uses thereof | |
DE59914061D1 (de) | Das gen prv-1 und dessen verwendung | |
NO971359L (no) | Humant galaktokinase-gen | |
WO2005017176A3 (en) | Methods for identifying risk of melanoma and treatments thereof | |
WO2001014418A3 (en) | p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF | |
IL135607A0 (en) | Wnt-1 inducible genes | |
TR200707455T2 (tr) | Karbon metabolizma ve enerji üretimindeki proteinleri kodlayan corynebacterium glutamicum genleri |